CLINICAL_TRIALS
trial_result
· 2020-01-07
Clinical Trial Update: A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia [Phase 2]
Summary
Phase 2 trial update for AGN-214868 in postherpetic neuralgia; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Neuralgia, Postherpetic | Phase 2 | Status: TERMINATED | Results posted: 2020-01-07